scholarly journals Introduction to the History and Current Status of Evidence-Based Korean Medicine: A Unique Integrated System of Allopathic and Holistic Medicine

2014 ◽  
Vol 2014 ◽  
pp. 1-6 ◽  
Author(s):  
Chang Shik Yin ◽  
Seong-Gyu Ko
Keyword(s):  
Evidence Based Medicine ◽  
Holistic Medicine ◽  
National Standard ◽  
Evidence Based ◽  
Korean Medicine ◽  
Classification Of Diseases ◽  
Recent Developments ◽  
Standard Classification ◽  
Based Medicine

Objectives. Korean medicine, an integrated allopathic and traditional medicine, has developed unique characteristics and has been active in contributing to evidence-based medicine. Recent developments in Korean medicine have not been as well disseminated as traditional Chinese medicine. This introduction to recent developments in Korean medicine will draw attention to, and facilitate, the advancement of evidence-based complementary alternative medicine (CAM).Methods and Results. The history of and recent developments in Korean medicine as evidence-based medicine are explored through discussions on the development of a national standard classification of diseases and study reports, ranging from basic research to newly developed clinical therapies. A national standard classification of diseases has been developed and revised serially into an integrated classification of Western allopathic and traditional holistic medicine disease entities. Standard disease classifications offer a starting point for the reliable gathering of evidence and provide a representative example of the unique status of evidence-based Korean medicine as an integration of Western allopathic medicine and traditional holistic medicine.Conclusions. Recent developments in evidence-based Korean medicine show a unique development in evidence-based medicine, adopting both Western allopathic and holistic traditional medicine. It is expected that Korean medicine will continue to be an important contributor to evidence-based medicine, encompassing conventional and complementary approaches.

scholarly journals The Square Curve Paradigm for Research in Alternative, Complementary, and Holistic Medicine: A Cost-Effective, Easy, and Scientifically Valid Design for Evidence-Based Medicine and Quality Improvement

2003 ◽  
Vol 3 ◽  
pp. 1117-1127 ◽  
Author(s):  
Soren Ventegodt ◽  
Niels JØrgen Andersen ◽  
Joav Merrick
Keyword(s):  
Quality Of Life ◽  
Evidence Based Medicine ◽  
Cost Effective ◽  
Holistic Medicine ◽  
Evidence Based ◽  
Life Questionnaire ◽  
Quality Of Life Questionnaire ◽  
New Research ◽  
Based Medicine

In this paper we present a new research paradigm for alternative, complementary, and holistic medicine — a low-cost, effective, and scientifically valid design for evidence-based medicine. Our aim is to find the simplest, cheapest, and most practical way to collect data of sufficient quality and validity to determine: (1) which kinds of treatment give a clinically relevant improvement to quality of life, health, and/or functionality; (2) which groups of patients can be aided by alternative, complementary, or holistic medicine; and (3) which therapists have the competence to achieve the clinically relevant improvements. Our solution to the problem is that a positive change in quality of life must be immediate to be taken as caused by an intervention. We define “immediate” as within 1 month of the intervention. If we can demonstrate a positive result with a group of chronic patients (20 or more patients who have had their disease or state of suffering for 1 year or more), who can be significantly helped within 1 month, and the situation is still improved 1 year after, we find it scientifically evidenced that this cure or intervention has helped the patients. We call this characteristic curve a “square curve”. If a global, generic, quality-of-life questionnaire like QOL5 or, even better, a QOL-Health-Ability questionnaire (a quality-of-life questionnaire combined with a self-evaluated health and ability to function questionnaire) is administered to the patients before and after the intervention, it is possible to document the effect of an intervention to a cost of only a few thousand Euros/USD. A general acceptance of this new research design will solve the problem that there is not enough money in alternative, complementary, and holistic medicine to pay the normal cost of a biomedical Cochrane study. As financial problems must not hinder the vital research in nonbiomedical medicine, we ask the scientific community to accept this new research standard.

scholarly journals Response to Miles and Mezzich

2014 ◽  
Vol 2 (1) ◽  
pp. 83
Author(s):  
Andrew Turner ◽  
John Blakey ◽  
Roger Kerry
Keyword(s):  
Evidence Based Medicine ◽  
Evidence Based ◽  
Patient Centred Care ◽  
The Past ◽  
Comprehensive Account ◽  
Practice Models ◽  
Recent Developments ◽  
Based Medicine

Miles and Mezzich offer a welcome and comprehensive account of historical recent developments in healthcare and the role of its practice models. They identify a ‘crisis’ in medicine, which seems to have occurred in part because the science of medicine has been over-emphasised and the importance of compassion and care de-emphasised.  As they point out, this crisis has been perceived to have evolved over the past one hundred years. Evidence Based Medicine (EBM) is suggested to be inadequate to solve the crisis and it may be the case that EBM, in fact, has precipitated it because it ignores patients qua persons. It is also suggested that Patient Centred Care (PCC) seeks to address the imbalance, but that this is inadequate, too. Between these existing views it is claimed that Person Centred Medicine (PCM) solves the crisis by giving persons and evidence their proper roles and relative importances

scholarly journals Systemic ozone applications, Major autohemotherapy and Rectal Insufflation, evaluated according to the International classification of Evidence-Based Medicine. A new basis for reimbursement of medical expenses by private and social insurances [abstract]

2019 ◽  
Vol 3 (4) ◽  
Author(s):  
Renate Viebahn-Hänsler ◽  
Olga Sonia Leon-Fernandez ◽  
Ziad Fahmy
Keyword(s):  
Evidence Based Medicine ◽  
Adverse Reactions ◽  
Controlled Trials ◽  
Evidence Based ◽  
Medical Expenses ◽  
Randomized Controlled ◽  
Inflammatory Conditions ◽  
Medical Ozone ◽  
Based Medicine

Now that indications are clearly defined, applications have mostly become standardized and the active mechanisms have been well confirmed, medical ozone application in the form of the low-dose concept, is established and proven as a complementary medical method in the treatment of chronic inflammations or diseases associated with chronic inflammatory conditions. More than 11,000 systemic ozone treatments in the form of Major Ozone Autohemotherapy (MAH) in 577 patients and ? 47,000 Rectal Insufflations (RI) in 716 patients in various clinical studies are subjected to critical clinical assessment and classification according to the criteria of evidence-based medicine (EBM). Statistically significant clinical and/or pharmacological improvements without side-effects or adverse reactions are found in all studies; special attention is drawn to maintaining hygiene when working with blood and to the use of ozone-resistent and biocompatible materials. On summarizing the evidence classification under RCT + CT (Randomized Controlled Trials + Controlled Trials), i.e. Levels Ib and IIa, 12 studies with 657 ozone-treated patients are obtained for MAH and 6 studies with 227 patients for RI. As a result of the evidence here assessed, the two systemic ozone applications, MAH and RI are part of evidence-based medicine. Both applications are effective, safe and economic.

scholarly journals Kyoto consensus - the new etiological classification of chronic gastritis and its discussion

2017 ◽  
Vol 95 (2) ◽  
pp. 181-188
Author(s):  
Yakov S. Tsimmerman ◽  
Yu. A. Zakharova
Keyword(s):  
Helicobacter Pylori ◽  
Gastric Mucosa ◽  
Chronic Gastritis ◽  
Evidence Based Medicine ◽  
Urease Activity ◽  
Evidence Based ◽  
Based Medicine ◽  
Gastric Microflora

The main provisions and headings of the new etiological classification of chronic gastritis are discussed in the context of recent data on the true role of Helicobacter pylori infection in the development of this pathology. The methods and results of the authors ’ investigations into gastric microflora are presented along with information about the frequency of detection of its different forms, concentration of microbial forms in gastric mucosa, their pathogenic properties including urease activity, and possible contribution to chronic gastritis etiology. The possibility of alcoholic and chemical chronic gastritis is discussed along with the role of these conditions in the development of stomach cancer. Special emphasis is laid on the disagreement between the adopted consensuses and principles of evidence-based medicine.

The State-Centred Nosology

2016 ◽  
Vol 11 (1-2) ◽  
pp. 100-132
Author(s):  
Taehyung Lee
Keyword(s):  
South Korea ◽  
Medical Service ◽  
Disease Classification ◽  
Traditional Korean Medicine ◽  
Korean Medicine ◽  
South Korean ◽  
Classification Of Diseases ◽  
Korean National Health Insurance ◽  
Standard Classification

Since 1951, when the Medical Service Act was enacted in South Korea, traditional Korean medicine has been an independent part of a dual medical system along with biomedicine. Despite several attempts to subordinate Korean medicine to biomedicine, Korean medicine has managed to remain an institutionally-independent system of medical care. However, in the years since the launch of the South Korean National Health Insurance Service in 1977, official regulations have required Korean medical nosology to be linked to biomedical nosology. In particular, during the four times of revision from 1979 to 2015, the originally separated disease classification of Korean medicine was gradually integrated into the Korean Standard Classification of Diseases (kcd), which heavily relies on biomedical nosology. The present study uses this nosological shift as a window to illustrate the transformation of Korean medicine in South Korea since the 1970s.

Hinchey Classification of Acute Diverticulitis

2017 ◽  
Author(s):  
Michael P. Catanzaro ◽  
Rachel J. Kwon
Keyword(s):  
Evidence Based Medicine ◽  
Paradigm Shift ◽  
Acute Diverticulitis ◽  
Scoring Systems ◽  
Historical Study ◽  
Evidence Based ◽  
Hinchey Classification ◽  
History Of ◽  
Based Medicine

This chapter provides a summary of a landmark historical study in surgery: the Hinchey classification of acute diverticulitis. It describes the history of the disease, gives a summary of the study including study design and results, and relates the study to a modern-day principle of evidence-based medicine: validation of scoring systems. Hinchey’s classification of diverticulitis has become the most widespread system and while the Hinchey score may currently have less clinical relevance as it did in his time, its publication and eventual adoption marked a practice-changing paradigm shift in the way diverticulitis is viewed and managed today.

Sign in / Sign up

Export Citation Format

Share Document